Camilla Myhre Sandberg
Board Member
Haematology
next cell pharma
Sweden
Biography
Camilla Myhre Sandberg is a Board Member of this company. He is also Independent board member with a marketing background in cell therapy and regenerative medicine, CEO at Miris Holding AB.
Research Interest
Haematology
